Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Correction to: Leukemia https://doi.org/10.1038/s41375-025-02567-w, published online 24 March 2025 In this article the author’s name D. A. Eichenauer. was incorrectly written as D. Eichenauer. The original article has been corrected. Additional information The original article can be found online at https://doi.org/10.1038/s41375-025-02567-w.
To the Editor: Progression-free survival (PFS) and overall survival (OS) are key indicators of treatment success in Hodgkin lymphoma (HL), both in the context of first-line treatment and in relapsed HL. While OS is often prioritized by regulatory authorities and health technology assessment bodies [1], PFS is highly relevant to patients and frequently serves as primary endpoint in clinical research [2].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
